We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Biopsies Do Not Promote Cancer Spread

By HospiMedica International staff writers
Posted on 19 Jan 2015
Print article
Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) does not cause pancreatic cancer to extend, according to a new study.

Researchers at the Mayo Clinic (Jacksonville, FL, USA) conducted a study involving 2,034 patients with locoregional pancreatic cancer who underwent curative intent surgery from 1998 to 2009; of these, 498 (24%) patients received EUS-FNA within the peri-diagnostic period (EUS-FNA group). The other 1,536 patients who did not receive EUS evaluation, or who underwent EUS without FNA, were included in the non-EUS-FNA group. Overall survival and pancreatic cancer-specific survival were compared after controlling for relevant covariates.

The results showed that during a mean follow-up time of 21 months, 285 patients (57%) in the EUS-FNA group and 1,167 patients (76%) in the non-EUS-FNA group died. Pancreatic cancer was identified as the cause of death for 251 patients (50%) in the EUS-FNA group and 980 patients (64%) in the non-EUS-FNA group. After controlling for age, race, gender, tumor histology, tumor stage, tumor grade, tumor location, radiation, chemotherapy, and other factors, EUS-FNA was marginally associated with improved overall survival, but did not affect cancer-specific survival. The study was published online on January 9, 2015, in Gut.

“Biopsies offer very valuable information that allow us to tailor treatment; in some cases, we can offer chemotherapy and radiation before surgery for a better outcome, and in other cases, we can avoid surgery and other therapy altogether,” said senior author, gastroenterologist Prof. Michael Wallace, MD, MPH. “Physicians and patients should feel reassured that a biopsy is very safe. We do millions of biopsies of cancer a year in the US, but one or two case studies have led to this common myth that biopsies spread cancer.”

During EUS-FNA, a flexible endoscope is inserted into the patient's body through the mouth or the anus. The tip of the endoscope has a small rotating ultrasound system that can peer about 10 cm into surrounding tissue. When the site that needs to be biopsied has been located, a fine needle is inserted down a canal in the endoscope and inserted into the area. Several samples of tissue are then retrieved and examined by a pathologist who is often in the room during the procedure.

Related Links:

Mayo Clinic


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Silver Member
ECG Management System
NEMS-Q

Print article

Channels

Critical Care

view channel
Image: The permeable wearable electronics developed for long-term biosignal monitoring (Photo courtesy of CityUHK)

Super Permeable Wearable Electronics Enable Long-Term Biosignal Monitoring

Wearable electronics have become integral to enhancing health and fitness by offering continuous tracking of physiological signals over extended periods. This monitoring is crucial for understanding an... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The PATHFAST hs-cTnI-II high-sensitivity troponin assay has been developed for the PATHFAST Biomarker Analyzer (Photo courtesy of Polymedco)

POC Myocardial Infarction Test Delivers Results in 17 Minutes

Chest pain is the second leading cause of emergency department (ED) visits by adults in the United States, generating over 7 million visits annually. In the event of a suspected heart attack, physicians... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.